✦ LIBER ✦
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia
✍ Scribed by Meir Wetzler; Chris Andrews; Laurie A. Ford; Sheila Tighe; Maurice Barcos; Sheila N. J. Sait; AnneMarie W. Block; Norma J. Nowak; Maria R. Baer; Eunice S. Wang; Heinz Baumann
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 357 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.